Citius Pharmaceuticals
CTXR
#10311
Rank
S$22.93 M
Marketcap
S$1.03
Share price
-4.51%
Change (1 day)
-17.41%
Change (1 year)

Earnings for Citius Pharmaceuticals (CTXR)

Earnings in 2025 (TTM): -S$51.03 Million

According to Citius Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$50.66 Million a decrease over its 2023 earnings that were of -S$47.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Citius Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$51.03 Million0.73%
2024 -S$50.66 Million5.78%
2023 -S$47.89 Million37.8%
2022 -S$34.75 Million13.08%
2021 -S$30.73 Million12.91%
2020 -S$27.22 Million33.5%
2019 -S$20.39 Million21.61%
2018 -S$16.77 Million14.93%
2017 -S$14.59 Million23.83%
2016 -S$11.78 Million180.39%
2015 -S$4.21 Million
2013 -S$0.72 Million2605.74%
2012 -S$0.03 Million4.81%
2011 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 282.65%๐Ÿ‡บ๐Ÿ‡ธ USA